Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer

Genes Chromosomes and Cancer

Volumn 25, Issue 2, 1999, Pages 108-114

  Hyytinen, Eija Riitta ^a   Frierson Jr , Henry F ^a   Boyd, James C ^a   Chung, Leland W K ^a   Dong, Jin Tang ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER GENETICS; CHROMOSOME 13Q; GENE DELETION; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

ADULT; AGED; CARCINOMA; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 13; DNA, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM METASTASIS; NUCLEIC ACID HYBRIDIZATION; PROSTATIC NEOPLASMS;

EID: 0032911123     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199906)25:2<108::AID-GCC6>3.0.CO;2-Y     Document Type: Article

References (42)

1. AJCC. 1997. AJCC cancer staging manual, 5th ed. Philadelphia: Lippincott-Raven.
2. Brooks JD, Bova GS, Isaacs WB. 1995. Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas. Prostate 26:35-39.
3. Cayanis E, Russo JJ, Kalachikov S, Ye X, Park SH, Sunjevaric I, Bonaldo MF, Lawton L, Venkatraj VS, Schon E, Soares MB, Rothstein R, Warburton D, Edelman IS, Zhang P, Efstratiadis A, Fischer SG. 1998. High-resolution YAC-cosmid-STS map of human chromosome 13. Genomics 47:26-13.
4. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH. 1994. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer 11:153-162.
5. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. 1996. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102.
6. Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ. 1996. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res 56:1142-1145.
7. Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S, Jenkins RB, Bostwick DG, Thibodeau SN. 1996. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 56:4475-4482.
8. Dotzenrath C, Teh BT, Farnebo F, Cupisti K, Svensson A, Toell A, Goretzki P, Larsson C. 1996. Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? J Clin Endocrinol Metab 81:3194-3196.
9. Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi OP. 1997. Genome screening by comparative genomic hybridization. Trends Genet 13:405-409.
10. Gronberg H, Isaacs SD, Smith JR, Carpten JD, Bova GS, Freije D, Xu J, Meyers DA, Collins FS, Trent JM, Walsh PC, Isaacs WB. 1997. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA 278:1251-1255.
11. Honchel R, Halling KC, Thibodeau SN. 1995. Genomic instability in neoplasia. Semin Cell Biol 6:45-52.
12. Hudson TJ, Stein LD, Gerety SS, Ma J, Castle AB, Silva J, Slonim DK, Baptista R, Kruglyak L, Xu SH, Hu X, Colbert AME, Rosenberg C, Reeve-Daly MP, Rozen S, Hui L, Wu X, Vestergaard C, Wilson KM, Bae JS, Maitra S, Ganiatsas S, Evans CA, DeAngelis MM, Ingalls KA, Nahf RW, Horton LT, Anderson MO, Collymore AJ, Ye W, Kouyoumjian V, Zemsteva IS, Tam J, Devine R, Courtney DF, Renaud TM, Nguyen H, O'Connor TJ, Fizames C, Faure S, Gyapay G, Dib C, Morissette J, Orlin JB, Birren BW, Goodman N, Weissenbach J, Hawkins TL, Foote S, Page DC, Lander ES. 1995. An STS-based map of the human genome. Science 270-1945-1954 (with supplementary data from the Whitehead Institute/MIT Center for Genome Research, Human Genetic Mapping Project, Data Release 12, July 1997).
13. Ittmann MM, Wieczorek R. 1996. Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas. Hum Pathol 27:28-34.
14. Kalachikov S, Migliazza A, Cayanis E, Fracchiolla NS, Bonaldo MF, Lawton L, Jelenc P, Ye X, Qu X, Chien M, Hauptschein R, Gaidano G, Vitolo L, Saglio G, Resegotti, L, Brodjansky V, Yankovsky N, Zhang P, Soares MB, Russo J, Edelman IS, Efstratiadis A, Dalla-Favera R, Fischer SG. 1997. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics 42:369-377.
15. Kubota Y, Fujinami K, Uemura H, Dobashi Y, Miyamoto H, Iwasaki Y, Kitamura H, Shuin T. 1995. Retinoblastoma gene mutations in primary human prostate cancer. Prostate 27:314-320.
16. Kunimi K, Bergerheim US, Larsson IL, Ekman P, Collins VP. 1991. Allelotyping of human prostatic adenocarcinoma. Genomics 11:530-536.
17. Kuroki T, Fujiwara Y, Nakamori S, Imaoka S, Kanematsu T, Nakamura Y. 1995. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br J Cacer 72:383-385.
18. Latil A, Cussenot O, Fournier G, Lidereau R. 1996. The BRCA2 gene is not relevant to sporadic prostate tumours [letter], Int J Cancer 66:282-283.
19. Li CD, Larsson C, Futreal A, Lancaster J, Phelan C, Aspenblad U, Sundelin B, Liu Y, Ekman P, Auer G, Bergerheim USR. 1998. Identification of two distinct deleted regions on chromosome 13 in prostate cancer. Oncogene 16:481-187.
20. Maestro R, Piccinin S, Doglioni C, Gasparotto D, Vukosavljevic T, Sulfaro S, Barzan L, Boiocchi M. 1996. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss. Cancer Res 56:1146-1150.
21. Melamed J, Einhorn JM, Ittmann MM. 1997. Allelic loss on chromosome 13q in human prostate carcinoma. Clin Cancer Res 3:1867-1872.
22. Moskaluk CA, Kern SE. 1997. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 150:1547-1532
23. Nelson JB, Nguyen SH, Zheng H, Ewing CM, Isaacs WB 1998. A frameshift mutation of the endothelen B receptor gene (EDNRB) in the prostate cancer cell line LNCaP. Proc Am Assoc Cancer Res 39:621.
24. Nouspikel T, Clarkson SG. 1994. Mutations that disable the DNA repair gene XPG in a xeroderma pigmentosum group G patient. Hum Mol Genet 3:963-967.
25. Nupponen NN, Hyytinen ER, Kallioniemi AH, Visakorpi T. 1998. Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization. Cancer Genet Cytogenet 101:53-57.
26. Pan Y, Matsuyama H, Wang N, Yoshihiro S, Haggarth L, Li C, Tribukait B, Ekman P, Bergerheim US. 1998. Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancer. Prostate 36: 31-38.
27. Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M, Chakravart A. 1994. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79:1257-1266.
28. Schoenberg M, Cairns P, Brooks JD, Marshall FF, Epstein JI, Isaacs WB, Sidransky D. 1995. Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney. Genes Chromosomes Cancer 12:76-80.
29. Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjord JE, Jonsson E. 1997. BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med 75:758-761.
30. Suzuki H, Komiya A, Emi M, Kuramochi H, Shiraishi T, Yatani R, Shimazaki J. 1996. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosomes Cancer 17:225-233
31. Tamura K, Zhang X, Murakami Y, Hirohashi S, Xu HJ, Hu SX, Benedict WF, Sekiya T. 1997. Deletion of three distinct regions on chromosome 13q in human non-small-ccll lung cancer, Int J Cancer 74:45-49.
32. Terrell RB, Wille AH, Cheville JC, Nystuen AM, Cohen MB, Sheffield VC. 1995. Microsatellite instability in adenocarcinoma of the prostate. Am J Pathol 147:799-805.
33. Theodorescu D, Broder SR, Boyd JC, Mills SE, Frierson HF Jr. 1997. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate. J Urol 158:131-137.
34. Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW, Dryja TR. 1993. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 17:535-543.
35. Trapman J, Sleddens HF, van der Weiden MM, Dinjens WN, Konig JJ, Schroder FH, Faber PW, Bosman FT. 1994. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54:6061-6064.
36. Uchida T, Wada C, Wang C, Ishida H, Egawa S, Yokoyama E, Ohtani H, Koshiba K. 1995. Microsatellite instability in prostate cancer. Oncogene 10:1019-1022.
37. van den Berg J, Johannsson O, Hakansson S, Olsson H, Borg A. 1996. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. Br J Cancer 74:1615-1619.
38. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP. 1995. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
39. Watanabe M, Imai H, Shiraishi T, Shimazaki J, Kotake T, Yatani R. 1995. Microsatellite instability in human prostate cancer. Br J Cancer 72:562-564.
40. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.
41. Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K, Ikenaga M, Kotoura Y, Sasaki MS. 1996. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas. Anticancer Res 16:2009-2015.
42. Yang-Feng TL, Han H, Chen KC, Li SB, Claus EB, Carcangiu ML, Chambers SK, Chambers JT, Schwartz PE. 1993. Allelic loss in ovarian cancer, Int J Cancer 54:546-551.